Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 09, 2019

SELL
$20.77 - $42.37 $41 - $84
-2 Closed
0 $0
Q4 2018

Jan 24, 2019

BUY
$20.07 - $46.7 $40 - $93
2 New
2 $0
Q3 2018

Oct 09, 2018

SELL
$41.2 - $59.85 $82 - $119
-2 Closed
0 $0
Q4 2017

Feb 16, 2018

BUY
$93.85 - $132.45 $187 - $264
2
2 $0

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $132M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.